Skip to main content
Top
Published in: European Journal of Clinical Microbiology & Infectious Diseases 3/2016

01-03-2016 | Original Article

Staphylococcus aureus bacteremic pneumonia

Authors: C. De la Calle, L. Morata, N. Cobos-Trigueros, J. A. Martinez, C. Cardozo, J. Mensa, A. Soriano

Published in: European Journal of Clinical Microbiology & Infectious Diseases | Issue 3/2016

Login to get access

Abstract

Staphylococcus aureus bacteremic pneumonia is an uncommon cause of hospitalization, with a high mortality rate. However, published reports are scarce and have included a small number of cases. All patients with S. aureus bacteremic pneumonia were prospectively collected in our institution from 2000 to 2014, and a retrospective revision was performed to identify risk factors associated with methicillin resistance and to update the mortality of this entity. A total of 98 patients were admitted: 57.1 % were due to methicillin-susceptible S. aureus (MSSA) and 42.8 % due to methicillin-resistant S. aureus (MRSA). In 40 patients (40.8 %), the infection was community acquired. Thirteen were ventilator-associated pneumonia episodes. The most frequent comorbidities were chronic lung disease (34.7 %), chronic renal failure (31.6 %), diabetes mellitus (29.6 %), and cardiovascular disease (31.6 %). Septic shock was present in 46 patients (46.9 %). The 30-day mortality was 46.9 %. MRSA infections occurred in older patients, more frequently with cardiovascular diseases, and they had received antibiotic treatment in the previous month more often than MSSA-infected patients. Patients with infection due to MSSA presented more frequently with septic shock, but they received more frequently appropriate empirical antibiotic therapy than patients with MRSA pneumonia (96 % vs. 38.1 %), and no differences in mortality were observed between both groups. In conclusion, S. aureus bacteremic pneumonia is a severe infection that, nowadays, affects people with comorbidities and the mortality is still high.
Literature
1.
go back to reference Kollef MH, Shorr A, Tabak YP, Gupta V, Liu LZ, Johannes RS (2005) Epidemiology and outcomes of health-care-associated pneumonia: results from a large US database of culture-positive pneumonia. Chest 128:3854–3862CrossRefPubMed Kollef MH, Shorr A, Tabak YP, Gupta V, Liu LZ, Johannes RS (2005) Epidemiology and outcomes of health-care-associated pneumonia: results from a large US database of culture-positive pneumonia. Chest 128:3854–3862CrossRefPubMed
2.
go back to reference González C, Rubio M, Romero-Vivas J, González M, Picazo JJ (2003) Staphylococcus aureus bacteremic pneumonia: differences between community and nosocomial acquisition. Int J Infect Dis 7:102–108CrossRefPubMed González C, Rubio M, Romero-Vivas J, González M, Picazo JJ (2003) Staphylococcus aureus bacteremic pneumonia: differences between community and nosocomial acquisition. Int J Infect Dis 7:102–108CrossRefPubMed
3.
go back to reference Watanakunakorn C (1987) Bacteremic Staphylococcus aureus pneumonia. Scand J Infect Dis 19(6):623–627CrossRefPubMed Watanakunakorn C (1987) Bacteremic Staphylococcus aureus pneumonia. Scand J Infect Dis 19(6):623–627CrossRefPubMed
4.
go back to reference DeRyke CA, Lodise TP Jr, Rybak MJ, McKinnon PS (2005) Epidemiology, treatment, and outcomes of nosocomial bacteremic Staphylococcus aureus pneumonia. Chest 128:1414–1422CrossRefPubMed DeRyke CA, Lodise TP Jr, Rybak MJ, McKinnon PS (2005) Epidemiology, treatment, and outcomes of nosocomial bacteremic Staphylococcus aureus pneumonia. Chest 128:1414–1422CrossRefPubMed
5.
go back to reference McCabe WR, Jackson GG (1962) Gram-negative bacteremia: II. clinical, laboratory, and therapeutic observations. Arch Intern Med 110:856–864CrossRef McCabe WR, Jackson GG (1962) Gram-negative bacteremia: II. clinical, laboratory, and therapeutic observations. Arch Intern Med 110:856–864CrossRef
6.
go back to reference Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, Knaus WA, Schein RM, Sibbald WJ (1992) Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 101(6):1644–1655CrossRefPubMed Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, Knaus WA, Schein RM, Sibbald WJ (1992) Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 101(6):1644–1655CrossRefPubMed
7.
go back to reference González C, Rubio M, Romero-Vivas J, González M, Picazo JJ (1999) Bacteremic pneumonia due to Staphylococcus aureus: a comparison of disease caused by methicillin-resistant and methicillin-susceptible organisms. Clin Infect Dis 29(5):1171–1177CrossRefPubMed González C, Rubio M, Romero-Vivas J, González M, Picazo JJ (1999) Bacteremic pneumonia due to Staphylococcus aureus: a comparison of disease caused by methicillin-resistant and methicillin-susceptible organisms. Clin Infect Dis 29(5):1171–1177CrossRefPubMed
8.
go back to reference González-Domínguez M, Seral C, Sáenz Y, Salvo S, Gude MJ, Porres-Osante N, Torres C, Castillo FJ (2012) Epidemiological features, resistance genes, and clones among community-onset methicillin-resistant Staphylococcus aureus (CO-MRSA) isolates detected in northern Spain. Int J Med Microbiol 302(7–8):320–326CrossRefPubMed González-Domínguez M, Seral C, Sáenz Y, Salvo S, Gude MJ, Porres-Osante N, Torres C, Castillo FJ (2012) Epidemiological features, resistance genes, and clones among community-onset methicillin-resistant Staphylococcus aureus (CO-MRSA) isolates detected in northern Spain. Int J Med Microbiol 302(7–8):320–326CrossRefPubMed
9.
go back to reference Marimón JM, Villar M, García-Arenzana JM, Caba Ide L, Pérez-Trallero E (2012) Molecular characterization of Staphylococcus aureus carrying the panton-valentine leucocidin genes in northern Spain. J Infect 64(1):47–53CrossRefPubMed Marimón JM, Villar M, García-Arenzana JM, Caba Ide L, Pérez-Trallero E (2012) Molecular characterization of Staphylococcus aureus carrying the panton-valentine leucocidin genes in northern Spain. J Infect 64(1):47–53CrossRefPubMed
10.
go back to reference Brauner J, Hallin M, Deplano A, De Mendonça R, Nonhoff C, De Ryck R, Roisin S, Struelens MJ, Denis O (2013) Community-acquired methicillin-resistant Staphylococcus aureus clones circulating in Belgium from 2005 to 2009: changing epidemiology. Eur J Clin Microbiol Infect Dis 32(5):613–620CrossRefPubMed Brauner J, Hallin M, Deplano A, De Mendonça R, Nonhoff C, De Ryck R, Roisin S, Struelens MJ, Denis O (2013) Community-acquired methicillin-resistant Staphylococcus aureus clones circulating in Belgium from 2005 to 2009: changing epidemiology. Eur J Clin Microbiol Infect Dis 32(5):613–620CrossRefPubMed
11.
go back to reference Catena V, Baiocchi M, Lentini P, Badolati L, Baccarin M, Del Monte DD, Rubini A (2012) Necrotizing pneumonia caused by Panton–Valentine leukocidin-producing methicillin-susceptible Staphylococcus aureus (MSSA). Infez Med 20(3):205–210PubMed Catena V, Baiocchi M, Lentini P, Badolati L, Baccarin M, Del Monte DD, Rubini A (2012) Necrotizing pneumonia caused by Panton–Valentine leukocidin-producing methicillin-susceptible Staphylococcus aureus (MSSA). Infez Med 20(3):205–210PubMed
12.
go back to reference Gillet Y, Issartel B, Vanhems P, Fournet JC, Lina G, Bes M, Vandenesch F, Piémont Y, Brousse N, Floret D, Etienne J (2002) Association between Staphylococcus aureus strains carrying gene for Panton–Valentine leukocidin and highly lethal necrotising pneumonia in young immunocompetent patients. Lancet 359(9308):753–759CrossRefPubMed Gillet Y, Issartel B, Vanhems P, Fournet JC, Lina G, Bes M, Vandenesch F, Piémont Y, Brousse N, Floret D, Etienne J (2002) Association between Staphylococcus aureus strains carrying gene for Panton–Valentine leukocidin and highly lethal necrotising pneumonia in young immunocompetent patients. Lancet 359(9308):753–759CrossRefPubMed
13.
go back to reference Chertow DS, Memoli MJ (2013) Bacterial coinfection in influenza: a grand rounds review. JAMA 309(3):275–282CrossRefPubMed Chertow DS, Memoli MJ (2013) Bacterial coinfection in influenza: a grand rounds review. JAMA 309(3):275–282CrossRefPubMed
14.
go back to reference Seligman R, Ramos-Lima LF, Oliveira Vdo A, Sanvicente C, Sartori J, Pacheco EF (2013) Risk factors for infection with multidrug-resistant bacteria in non-ventilated patients with hospital-acquired pneumonia. J Bras Pneumol 39(3):339–348PubMedCentralCrossRefPubMed Seligman R, Ramos-Lima LF, Oliveira Vdo A, Sanvicente C, Sartori J, Pacheco EF (2013) Risk factors for infection with multidrug-resistant bacteria in non-ventilated patients with hospital-acquired pneumonia. J Bras Pneumol 39(3):339–348PubMedCentralCrossRefPubMed
15.
go back to reference Graffunder EM, Venezia RA (2002) Risk factors associated with nosocomial methicillin-resistant Staphylococcus aureus (MRSA) infection including previous use of antimicrobials. J Antimicrob Chemother 49(6):999–1005CrossRefPubMed Graffunder EM, Venezia RA (2002) Risk factors associated with nosocomial methicillin-resistant Staphylococcus aureus (MRSA) infection including previous use of antimicrobials. J Antimicrob Chemother 49(6):999–1005CrossRefPubMed
16.
go back to reference Ortega M, Marco F, Soriano A, Almela M, Martínez JA, Muñoz A, Mensa J (2008) Methicillin-resistant Staphylococcus aureus bacteremia. Predictor factors for an isolate with a vancomycin minimal inhibitory concentration > or =2 mg/l. Rev Esp Quimioter 21(2):93–98PubMed Ortega M, Marco F, Soriano A, Almela M, Martínez JA, Muñoz A, Mensa J (2008) Methicillin-resistant Staphylococcus aureus bacteremia. Predictor factors for an isolate with a vancomycin minimal inhibitory concentration > or =2 mg/l. Rev Esp Quimioter 21(2):93–98PubMed
17.
go back to reference Lalueza A, Chaves F, San Juan R, Daskalaki M, Otero JR, Aguado JM (2010) Is high vancomycin minimum inhibitory concentration a good marker to predict the outcome of methicillin-resistant Staphylococcus aureus bacteremia? J Infect Dis 201(2):311–312CrossRefPubMed Lalueza A, Chaves F, San Juan R, Daskalaki M, Otero JR, Aguado JM (2010) Is high vancomycin minimum inhibitory concentration a good marker to predict the outcome of methicillin-resistant Staphylococcus aureus bacteremia? J Infect Dis 201(2):311–312CrossRefPubMed
18.
go back to reference Cameron DR, Howden BP, Peleg AY (2011) The interface between antibiotic resistance and virulence in Staphylococcus aureus and its impact upon clinical outcomes. Clin Infect Dis 53(6):576–582CrossRefPubMed Cameron DR, Howden BP, Peleg AY (2011) The interface between antibiotic resistance and virulence in Staphylococcus aureus and its impact upon clinical outcomes. Clin Infect Dis 53(6):576–582CrossRefPubMed
19.
go back to reference Cameron DR, Ward DV, Kostoulias X, Howden BP, Moellering RC Jr, Eliopoulos GM, Peleg AY (2012) Serine/threonine phosphatase Stp1 contributes to reduced susceptibility to vancomycin and virulence in Staphylococcus aureus. J Infect Dis 205(11):1677–1687PubMedCentralCrossRefPubMed Cameron DR, Ward DV, Kostoulias X, Howden BP, Moellering RC Jr, Eliopoulos GM, Peleg AY (2012) Serine/threonine phosphatase Stp1 contributes to reduced susceptibility to vancomycin and virulence in Staphylococcus aureus. J Infect Dis 205(11):1677–1687PubMedCentralCrossRefPubMed
20.
go back to reference Peleg AY, Monga D, Pillai S, Mylonakis E, Moellering RC Jr, Eliopoulos GM (2009) Reduced susceptibility to vancomycin influences pathogenicity in Staphylococcus aureus infection. J Infect Dis 199(4):532–536PubMedCentralCrossRefPubMed Peleg AY, Monga D, Pillai S, Mylonakis E, Moellering RC Jr, Eliopoulos GM (2009) Reduced susceptibility to vancomycin influences pathogenicity in Staphylococcus aureus infection. J Infect Dis 199(4):532–536PubMedCentralCrossRefPubMed
21.
go back to reference Cheung GY, Kretschmer D, Duong AC, Yeh AJ, Ho TV, Chen Y, Joo HS, Kreiswirth BN, Peschel A, Otto M (2014) Production of an attenuated phenol-soluble modulin variant unique to the MRSA clonal complex 30 increases severity of bloodstream infection. PLoS Pathog 10(8):e1004298PubMedCentralCrossRefPubMed Cheung GY, Kretschmer D, Duong AC, Yeh AJ, Ho TV, Chen Y, Joo HS, Kreiswirth BN, Peschel A, Otto M (2014) Production of an attenuated phenol-soluble modulin variant unique to the MRSA clonal complex 30 increases severity of bloodstream infection. PLoS Pathog 10(8):e1004298PubMedCentralCrossRefPubMed
22.
go back to reference Ratzinger F, Eichbichler K, Schuardt M, Tsirkinidou I, Mitteregger D, Haslacher H, Perkmann T, Schmetterer KG, Doffner G, Burgmann H (2015) Sepsis in standard care: patients’ characteristics, effectiveness of antimicrobial therapy and patient outcome—a cohort study. Infection 43(3):345–352CrossRefPubMed Ratzinger F, Eichbichler K, Schuardt M, Tsirkinidou I, Mitteregger D, Haslacher H, Perkmann T, Schmetterer KG, Doffner G, Burgmann H (2015) Sepsis in standard care: patients’ characteristics, effectiveness of antimicrobial therapy and patient outcome—a cohort study. Infection 43(3):345–352CrossRefPubMed
23.
go back to reference Chen HC, Lin WL, Lin CC, Hsieh WH, Hsieh CH, Wu MH, Wu JY, Lee CC (2013) Outcome of inadequate empirical antibiotic therapy in emergency department patients with community-onset bloodstream infections. J Antimicrob Chemother 68(4):947–953CrossRefPubMed Chen HC, Lin WL, Lin CC, Hsieh WH, Hsieh CH, Wu MH, Wu JY, Lee CC (2013) Outcome of inadequate empirical antibiotic therapy in emergency department patients with community-onset bloodstream infections. J Antimicrob Chemother 68(4):947–953CrossRefPubMed
24.
go back to reference Mandell LA, Wunderink RG, Anzueto A, Bartlett JG, Campbell GD, Dean NC, Dowell SF, File TM Jr, Musher DM, Niederman MS, Torres A, Whitney CG; Infectious Diseases Society of America; American Thoracic Society (2007) Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis 44(Suppl 2):S27–S72 Mandell LA, Wunderink RG, Anzueto A, Bartlett JG, Campbell GD, Dean NC, Dowell SF, File TM Jr, Musher DM, Niederman MS, Torres A, Whitney CG; Infectious Diseases Society of America; American Thoracic Society (2007) Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis 44(Suppl 2):S27–S72
25.
go back to reference Robicsek A, Suseno M, Beaumont JL, Thomson RB Jr, Peterson LR (2008) Prediction of methicillin-resistant Staphylococcus aureus involvement in disease sites by concomitant nasal sampling. J Clin Microbiol 46(2):588–592PubMedCentralCrossRefPubMed Robicsek A, Suseno M, Beaumont JL, Thomson RB Jr, Peterson LR (2008) Prediction of methicillin-resistant Staphylococcus aureus involvement in disease sites by concomitant nasal sampling. J Clin Microbiol 46(2):588–592PubMedCentralCrossRefPubMed
26.
go back to reference Tilahun B, Faust AC, McCorstin P, Ortegon A (2015) Nasal colonization and lower respiratory tract infections with methicillin-resistant Staphylococcus aureus. Am J Crit Care 24(1):8–12CrossRefPubMed Tilahun B, Faust AC, McCorstin P, Ortegon A (2015) Nasal colonization and lower respiratory tract infections with methicillin-resistant Staphylococcus aureus. Am J Crit Care 24(1):8–12CrossRefPubMed
27.
go back to reference Dangerfield B, Chung A, Webb B, Seville MT (2014) Predictive value of methicillin-resistant Staphylococcus aureus (MRSA) nasal swab PCR assay for MRSA pneumonia. Antimicrob Agents Chemother 58(2):859–864PubMedCentralCrossRefPubMed Dangerfield B, Chung A, Webb B, Seville MT (2014) Predictive value of methicillin-resistant Staphylococcus aureus (MRSA) nasal swab PCR assay for MRSA pneumonia. Antimicrob Agents Chemother 58(2):859–864PubMedCentralCrossRefPubMed
Metadata
Title
Staphylococcus aureus bacteremic pneumonia
Authors
C. De la Calle
L. Morata
N. Cobos-Trigueros
J. A. Martinez
C. Cardozo
J. Mensa
A. Soriano
Publication date
01-03-2016
Publisher
Springer Berlin Heidelberg
Published in
European Journal of Clinical Microbiology & Infectious Diseases / Issue 3/2016
Print ISSN: 0934-9723
Electronic ISSN: 1435-4373
DOI
https://doi.org/10.1007/s10096-015-2566-8

Other articles of this Issue 3/2016

European Journal of Clinical Microbiology & Infectious Diseases 3/2016 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine